Personal tools

Coexpression cluster:C55: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
Line 1: Line 1:
{{Coexpression_clusters
{
|coexpression_dpi_cluster_scores_median=0,0,0,0

Latest revision as of 10:19, 17 September 2013


Full id: C55_hepatocellular_Intestinal_liver_Prostate_fibrosarcoma_Hepatocyte_hepatoblastoma



Phase1 CAGE Peaks

Hg19::chr10:106013815..106013828,+p9@GSTO1
Hg19::chr10:54515261..54515272,-p4@ENST00000443523
Hg19::chr10:73107816..73107832,-p@chr10:73107816..73107832
-
Hg19::chr10:73107857..73107859,-p@chr10:73107857..73107859
-
Hg19::chr10:7745303..7745349,+p1@ITIH2
Hg19::chr11:111230079..111230088,-p8@POU2AF1
Hg19::chr11:111230109..111230119,-p5@POU2AF1
Hg19::chr11:111788738..111788757,+p7@C11orf52
Hg19::chr11:19998187..19998192,+p@chr11:19998187..19998192
+
Hg19::chr11:19998278..19998297,+p@chr11:19998278..19998297
+
Hg19::chr11:22696465..22696478,+p15@GAS2
Hg19::chr11:2753785..2753815,-p@chr11:2753785..2753815
-
Hg19::chr11:2753854..2753856,-p@chr11:2753854..2753856
-
Hg19::chr11:34380681..34380705,-p@chr11:34380681..34380705
-
Hg19::chr11:46741130..46741141,+p@chr11:46741130..46741141
+
Hg19::chr11:61102006..61102013,+p5@DAK
Hg19::chr11:65384046..65384063,-p@chr11:65384046..65384063
-
Hg19::chr12:24191262..24191291,-p@chr12:24191262..24191291
-
Hg19::chr12:6335301..6335315,+p@chr12:6335301..6335315
+
Hg19::chr12:9266667..9266681,-p@chr12:9266667..9266681
-
Hg19::chr13:24190079..24190098,+p@chr13:24190079..24190098
+
Hg19::chr13:52586085..52586102,-p2@ATP7B
Hg19::chr13:52733937..52733950,-p8@NEK3
Hg19::chr13:52733980..52734002,-p4@NEK3
Hg19::chr13:76334992..76335005,+p21@LMO7
Hg19::chr13:98921900..98921918,+p@chr13:98921900..98921918
+
Hg19::chr14:105233283..105233290,-p@chr14:105233283..105233290
-
Hg19::chr14:24050941..24050946,+p@chr14:24050941..24050946
+
Hg19::chr14:24053130..24053137,-p@chr14:24053130..24053137
-
Hg19::chr14:24105566..24105579,+p1@DHRS2
Hg19::chr14:24105827..24105838,+p7@DHRS2
Hg19::chr14:24109018..24109027,+p@chr14:24109018..24109027
+
Hg19::chr14:24110986..24110989,+p@chr14:24110986..24110989
+
Hg19::chr14:24113321..24113333,+p@chr14:24113321..24113333
+
Hg19::chr14:38334576..38334578,+p@chr14:38334576..38334578
+
Hg19::chr14:39644079..39644088,+p41@PNN
Hg19::chr14:54425475..54425500,-p8@BMP4
Hg19::chr14:88490934..88490953,+p1@ENST00000555996
p1@ENST00000556673
Hg19::chr14:94947361..94947376,+p@chr14:94947361..94947376
+
Hg19::chr14:94947386..94947396,+p@chr14:94947386..94947396
+
Hg19::chr15:101631815..101631824,-p@chr15:101631815..101631824
-
Hg19::chr15:40294703..40294711,+p12@EIF2AK4
Hg19::chr15:40294718..40294730,+p10@EIF2AK4
Hg19::chr15:40294745..40294760,+p6@EIF2AK4
Hg19::chr15:40294761..40294774,+p3@EIF2AK4
Hg19::chr15:40294788..40294801,+p9@EIF2AK4
Hg19::chr15:40294803..40294815,+p8@EIF2AK4
Hg19::chr15:56537258..56537268,-p@chr15:56537258..56537268
-
Hg19::chr15:56537273..56537289,-p@chr15:56537273..56537289
-
Hg19::chr15:56537291..56537312,-p@chr15:56537291..56537312
-
Hg19::chr15:60695016..60695033,-p5@ANXA2
Hg19::chr15:60695045..60695056,-p10@ANXA2
Hg19::chr15:60695071..60695089,-p6@ANXA2
Hg19::chr15:60695090..60695093,-p19@ANXA2
Hg19::chr15:63179288..63179293,+p@chr15:63179288..63179293
+
Hg19::chr15:65670329..65670351,-p1@IGDCC3
Hg19::chr16:15489650..15489670,+p4@MPV17L
Hg19::chr16:30124013..30124025,-p@chr16:30124013..30124025
-
Hg19::chr16:30124030..30124050,-p@chr16:30124030..30124050
-
Hg19::chr16:524869..524883,+p5@RAB11FIP3
Hg19::chr16:85569070..85569077,-p@chr16:85569070..85569077
-
Hg19::chr16:85832119..85832145,+p@chr16:85832119..85832145
+
Hg19::chr16:85832146..85832165,+p@chr16:85832146..85832165
+
Hg19::chr17:14276770..14276781,+p@chr17:14276770..14276781
+
Hg19::chr17:29827153..29827159,+p@chr17:29827153..29827159
+
Hg19::chr17:41006104..41006119,+p4@AOC3
Hg19::chr17:41327736..41327748,+p3@CU679501
Hg19::chr17:41327760..41327769,+p4@CU679501
Hg19::chr17:41327771..41327784,+p2@CU679501
Hg19::chr17:41622731..41622764,-p5@ETV4
Hg19::chr17:41622765..41622821,-p2@ETV4
Hg19::chr17:48616092..48616118,+p@chr17:48616092..48616118
+
Hg19::chr17:48616143..48616150,+p@chr17:48616143..48616150
+
Hg19::chr17:53343202..53343207,+p9@HLF
Hg19::chr17:53343577..53343588,+p@chr17:53343577..53343588
+
Hg19::chr17:53343589..53343600,+p@chr17:53343589..53343600
+
Hg19::chr17:53343606..53343643,+p@chr17:53343606..53343643
+
Hg19::chr17:53344945..53344977,+p2@HLF
Hg19::chr17:55657847..55657884,+p@chr17:55657847..55657884
+
Hg19::chr17:7082560..7082572,-p4@ASGR1
Hg19::chr17:7082573..7082598,-p5@ASGR1
Hg19::chr17:73888918..73888931,-p@chr17:73888918..73888931
-
Hg19::chr17:74372662..74372664,+p35@SPHK1
Hg19::chr17:79952836..79952845,-p@chr17:79952836..79952845
-
Hg19::chr17:79953210..79953234,+p@chr17:79953210..79953234
+
Hg19::chr17:79953236..79953247,+p@chr17:79953236..79953247
+
Hg19::chr17:79953252..79953267,+p@chr17:79953252..79953267
+
Hg19::chr17:79953269..79953276,+p@chr17:79953269..79953276
+
Hg19::chr17:79953286..79953289,+p@chr17:79953286..79953289
+
Hg19::chr17:79953290..79953297,+p@chr17:79953290..79953297
+
Hg19::chr17:79953310..79953319,+p@chr17:79953310..79953319
+
Hg19::chr17:79953455..79953493,+p@chr17:79953455..79953493
+
Hg19::chr17:80278355..80278368,+p@chr17:80278355..80278368
+
Hg19::chr17:80283509..80283514,+p@chr17:80283509..80283514
+
Hg19::chr17:80283535..80283543,+p@chr17:80283535..80283543
+
Hg19::chr18:32508476..32508518,-p@chr18:32508476..32508518
-
Hg19::chr18:56080911..56080917,-p@chr18:56080911..56080917
-
Hg19::chr19:1051123..1051134,+p@chr19:1051123..1051134
+
Hg19::chr19:11347228..11347241,-p@chr19:11347228..11347241
-
Hg19::chr19:18492973..18492983,+p@chr19:18492973..18492983
+
Hg19::chr19:34664331..34664347,-p@chr19:34664331..34664347
-
Hg19::chr19:36611230..36611239,+p@chr19:36611230..36611239
+
Hg19::chr19:4582421..4582426,-p@chr19:4582421..4582426
-
Hg19::chr19:51858009..51858048,-p2@ETFB
Hg19::chr19:54368001..54368022,+p1@ENST00000422045
Hg19::chr19:54368932..54368952,+p@chr19:54368932..54368952
+
Hg19::chr1:10231286..10231331,+p6@UBE4B
Hg19::chr1:183418614..183418617,+p@chr1:183418614..183418617
+
Hg19::chr1:2066387..2066399,+p27@PRKCZ
Hg19::chr1:20813184..20813200,-p16@CAMK2N1
Hg19::chr1:20813209..20813232,-p8@CAMK2N1
Hg19::chr1:230845029..230845045,-p@chr1:230845029..230845045
-
Hg19::chr1:3208995..3209014,+p@chr1:3208995..3209014
+
Hg19::chr1:33160831..33160852,-p9@SYNC
Hg19::chr1:33160859..33160872,-p12@SYNC
Hg19::chr1:3373381..3373424,-p@chr1:3373381..3373424
-
Hg19::chr1:3373997..3374006,+p@chr1:3373997..3374006
+
Hg19::chr1:3374197..3374210,+p@chr1:3374197..3374210
+
Hg19::chr1:43502138..43502148,+p@chr1:43502138..43502148
+
Hg19::chr1:54821913..54821929,-p@chr1:54821913..54821929
-
Hg19::chr1:94057754..94057796,+p1@ENST00000431770
Hg19::chr1:9777591..9777605,+p@chr1:9777591..9777605
+
Hg19::chr20:23639928..23639941,+p@chr20:23639928..23639941
+
Hg19::chr20:4152356..4152363,+p8@SMOX
Hg19::chr20:57587795..57587811,+p@chr20:57587795..57587811
+
Hg19::chr20:62369476..62369487,+p7@LIME1
Hg19::chr20:62369494..62369503,+p9@LIME1
Hg19::chr20:62372434..62372484,+p5@SLC2A4RG
Hg19::chr20:62655807..62655838,+p@chr20:62655807..62655838
+
Hg19::chr20:62655876..62655885,+p@chr20:62655876..62655885
+
Hg19::chr20:62655886..62655904,+p@chr20:62655886..62655904
+
Hg19::chr20:62655920..62655936,+p@chr20:62655920..62655936
+
Hg19::chr20:62667340..62667354,+p8@LINC00176
Hg19::chr21:16816643..16816654,-p@chr21:16816643..16816654
-
Hg19::chr21:42694815..42694825,+p@chr21:42694815..42694825
+
Hg19::chr21:44590204..44590215,+p7@CRYAA
Hg19::chr21:44590245..44590255,+p8@CRYAA
Hg19::chr21:44591740..44591760,+p4@CRYAA
Hg19::chr21:44591794..44591807,+p5@CRYAA
Hg19::chr21:44591824..44591835,+p9@CRYAA
Hg19::chr21:45902872..45902891,+p@chr21:45902872..45902891
+
Hg19::chr21:45902929..45902938,+p@chr21:45902929..45902938
+
Hg19::chr21:45926343..45926357,-p@chr21:45926343..45926357
-
Hg19::chr22:24406066..24406088,+p@chr22:24406066..24406088
+
Hg19::chr22:24406119..24406125,+p@chr22:24406119..24406125
+
Hg19::chr22:29965263..29965274,-p@chr22:29965263..29965274
-
Hg19::chr22:29965275..29965284,-p@chr22:29965275..29965284
-
Hg19::chr22:49088918..49088921,+p18@FAM19A5
Hg19::chr22:49089001..49089013,+p9@FAM19A5
Hg19::chr22:49089016..49089036,+p8@FAM19A5
Hg19::chr22:49098490..49098492,-p@chr22:49098490..49098492
-
Hg19::chr2:101869394..101869415,+p5@C2orf29
Hg19::chr2:113977697..113977733,-p6@PAX8
Hg19::chr2:11494310..11494313,-p@chr2:11494310..11494313
-
Hg19::chr2:11505541..11505552,-p2@ENST00000430897
Hg19::chr2:11505555..11505581,-p1@ENST00000430897
Hg19::chr2:11679754..11679759,+p26@GREB1
Hg19::chr2:118847254..118847263,+p@chr2:118847254..118847263
+
Hg19::chr2:128928037..128928045,+p19@UGGT1
Hg19::chr2:128928046..128928053,+p16@UGGT1
Hg19::chr2:128928056..128928064,+p12@UGGT1
Hg19::chr2:128928065..128928077,+p8@UGGT1
Hg19::chr2:128928091..128928101,+p13@UGGT1
Hg19::chr2:128928131..128928144,+p7@UGGT1
Hg19::chr2:138722283..138722293,+p@chr2:138722283..138722293
+
Hg19::chr2:150443743..150443763,-p5@MMADHC
Hg19::chr2:152832119..152832136,-p@chr2:152832119..152832136
-
Hg19::chr2:161348944..161348970,-p@chr2:161348944..161348970
-
Hg19::chr2:169047242..169047254,-p@chr2:169047242..169047254
-
Hg19::chr2:171571796..171571808,+p4@SP5
Hg19::chr2:171571810..171571813,+p12@SP5
Hg19::chr2:171571827..171571853,+p1@SP5
Hg19::chr2:178129680..178129691,-p35@NFE2L2
Hg19::chr2:180209292..180209307,+p@chr2:180209292..180209307
+
Hg19::chr2:188375568..188375573,+p@chr2:188375568..188375573
+
Hg19::chr2:201171049..201171056,+p17@SPATS2L
Hg19::chr2:219613831..219613849,+p@chr2:219613831..219613849
+
Hg19::chr2:223535653..223535657,+p@chr2:223535653..223535657
+
Hg19::chr2:233734968..233734987,+p2@C2orf82
Hg19::chr2:233734998..233735010,+p7@C2orf82
Hg19::chr2:238510264..238510281,-p12@RAB17
Hg19::chr2:241816029..241816038,+p8@AGXT
Hg19::chr2:242710114..242710126,+p@chr2:242710114..242710126
+
Hg19::chr2:242710131..242710142,+p@chr2:242710131..242710142
+
Hg19::chr2:242710144..242710150,+p@chr2:242710144..242710150
+
Hg19::chr2:242710152..242710173,+p@chr2:242710152..242710173
+
Hg19::chr2:242750092..242750115,-p1@D55640
Hg19::chr2:242750122..242750135,-p2@D55640
Hg19::chr2:242750202..242750210,-p5@D55640
Hg19::chr2:39743444..39743454,+p@chr2:39743444..39743454
+
Hg19::chr2:61245234..61245263,-p7@PUS10
Hg19::chr2:62797131..62797150,-p@chr2:62797131..62797150
-
Hg19::chr2:69408193..69408204,+p@chr2:69408193..69408204
+
Hg19::chr2:69507486..69507504,+p@chr2:69507486..69507504
+
Hg19::chr2:71357490..71357507,+p5@MPHOSPH10
Hg19::chr2:71357516..71357523,+p14@MPHOSPH10
Hg19::chr2:71357527..71357532,+p15@MPHOSPH10
Hg19::chr2:71357575..71357580,+p16@MPHOSPH10
Hg19::chr2:71357689..71357700,+p7@MPHOSPH10
Hg19::chr2:71358627..71358668,-p@chr2:71358627..71358668
-
Hg19::chr2:74669468..74669481,-p18@RTKN
Hg19::chr2:74669504..74669520,-p9@RTKN
Hg19::chr2:74725787..74725817,+p@chr2:74725787..74725817
+
Hg19::chr2:74728801..74728811,+p@chr2:74728801..74728811
+
Hg19::chr2:74729768..74729780,+p7@LOC151534
Hg19::chr2:75749739..75749750,-p13@FAM176A
Hg19::chr2:8765741..8765752,+p@chr2:8765741..8765752
+
Hg19::chr3:115511314..115511328,-p@chr3:115511314..115511328
-
Hg19::chr3:115511342..115511357,-p@chr3:115511342..115511357
-
Hg19::chr3:123518704..123518728,-p28@MYLK
Hg19::chr3:123518738..123518771,-p20@MYLK
Hg19::chr3:126243032..126243049,+p4@CHST13
Hg19::chr3:149103836..149103848,+p@chr3:149103836..149103848
+
Hg19::chr3:24563837..24563845,-p@chr3:24563837..24563845
-
Hg19::chr3:53878829..53878837,-p8@CHDH
Hg19::chr3:8693729..8693738,-p4@C3orf32
Hg19::chr3:8693740..8693751,-p3@C3orf32
Hg19::chr4:14507912..14507929,-p1@MTND2P31
Hg19::chr4:69886109..69886116,-p2@UGT2B10
Hg19::chr4:73969908..73969969,-p7@ANKRD17
Hg19::chr4:74281831..74281845,+p8@ALB
Hg19::chr4:74281852..74281859,+p42@ALB
Hg19::chr4:74281935..74281942,+p34@ALB
Hg19::chr4:74301931..74301947,+p1@AFP
Hg19::chr4:74303903..74303913,+p@chr4:74303903..74303913
+
Hg19::chr4:74306401..74306416,+p@chr4:74306401..74306416
+
Hg19::chr4:74308029..74308041,+p6@AFP
Hg19::chr4:74313175..74313185,+p@chr4:74313175..74313185
+
Hg19::chr4:74313240..74313247,+p@chr4:74313240..74313247
+
Hg19::chr4:7532912..7532926,+p@chr4:7532912..7532926
+
Hg19::chr5:176514413..176514425,+p4@FGFR4
Hg19::chr5:27472506..27472517,+p3@ENST00000503107
p3@ENST00000505775
p3@ENST00000514844
Hg19::chr5:27472552..27472563,+p2@ENST00000503107
p2@ENST00000505775
p2@ENST00000514844
Hg19::chr5:73109145..73109156,+p8@RGNEF
Hg19::chr5:73109161..73109171,+p10@RGNEF
Hg19::chr5:73109177..73109186,+p14@RGNEF
Hg19::chr5:78281580..78281593,-p9@ARSB
Hg19::chr5:78281603..78281617,-p4@ARSB
Hg19::chr5:78281623..78281638,-p6@ARSB
Hg19::chr5:99382075..99382076,-p@chr5:99382075..99382076
-
Hg19::chr6:111067964..111067988,-p@chr6:111067964..111067988
-
Hg19::chr6:1228850..1228866,-p@chr6:1228850..1228866
-
Hg19::chr6:1228913..1228926,-p@chr6:1228913..1228926
-
Hg19::chr6:131148538..131148554,+p1@LOC100507203
Hg19::chr6:131956661..131956698,+p@chr6:131956661..131956698
+
Hg19::chr6:131956703..131956715,+p@chr6:131956703..131956715
+
Hg19::chr6:142652494..142652496,+p@chr6:142652494..142652496
+
Hg19::chr6:143382705..143382719,-p@chr6:143382705..143382719
-
Hg19::chr6:155649792..155649806,-p@chr6:155649792..155649806
-
Hg19::chr6:155649817..155649830,-p@chr6:155649817..155649830
-
Hg19::chr6:155649833..155649855,-p@chr6:155649833..155649855
-
Hg19::chr6:167413386..167413410,-p@chr6:167413386..167413410
-
Hg19::chr6:17744923..17744930,-p@chr6:17744923..17744930
-
Hg19::chr6:31633199..31633214,+p10@CSNK2B
Hg19::chr6:31833005..31833017,-p@chr6:31833005..31833017
-
Hg19::chr6:31833124..31833134,-p@chr6:31833124..31833134
-
Hg19::chr7:100334542..100334575,+p@chr7:100334542..100334575
+
Hg19::chr7:116451100..116451116,+p7@CAPZA2
Hg19::chr7:137749745..137749769,+p@chr7:137749745..137749769
+
Hg19::chr7:137749779..137749804,+p@chr7:137749779..137749804
+
Hg19::chr7:138001633..138001637,+p@chr7:138001633..138001637
+
Hg19::chr7:138037598..138037605,+p@chr7:138037598..138037605
+
Hg19::chr7:138250447..138250450,-p@chr7:138250447..138250450
-
Hg19::chr7:149572014..149572037,+p5@ATP6V0E2
Hg19::chr7:149572065..149572077,+p7@ATP6V0E2
Hg19::chr7:2661815..2661826,-p@chr7:2661815..2661826
-
Hg19::chr7:27161985..27162002,-p@chr7:27161985..27162002
-
Hg19::chr7:27162005..27162017,-p@chr7:27162005..27162017
-
Hg19::chr7:27162134..27162170,+p1@ENST00000521159
Hg19::chr7:27162183..27162194,+p1@ENST00000521687
Hg19::chr7:55246785..55246802,+p@chr7:55246785..55246802
+
Hg19::chr7:7196702..7196714,+p6@C1GALT1
Hg19::chr8:129569033..129569049,+p@chr8:129569033..129569049
+
Hg19::chr8:13134195..13134210,-p19@DLC1
Hg19::chr8:142410662..142410702,+p@chr8:142410662..142410702
+
Hg19::chr8:143844467..143844506,+p1@ENST00000523657
Hg19::chr8:144601518..144601527,-p@chr8:144601518..144601527
-
Hg19::chr8:145148703..145148707,+p@chr8:145148703..145148707
+
Hg19::chr8:146051115..146051126,-p@chr8:146051115..146051126
-
Hg19::chr8:17773397..17773420,-p@chr8:17773397..17773420
-
Hg19::chr8:17773488..17773502,-p@chr8:17773488..17773502
-
Hg19::chr8:17773510..17773522,-p@chr8:17773510..17773522
-
Hg19::chr8:17773586..17773592,-p@chr8:17773586..17773592
-
Hg19::chr8:17773774..17773784,-p@chr8:17773774..17773784
-
Hg19::chr8:22414130..22414179,+p22@SORBS3
Hg19::chr8:22414182..22414204,+p39@SORBS3
Hg19::chr8:22414219..22414229,+p@chr8:22414219..22414229
+
Hg19::chr8:42424452..42424454,+p@chr8:42424452..42424454
+
Hg19::chr9:103947331..103947342,+p14@LPPR1
Hg19::chr9:107651889..107651907,-p10@ABCA1
Hg19::chr9:107651917..107651931,-p11@ABCA1
Hg19::chr9:107651937..107651972,-p3@ABCA1
Hg19::chr9:111648081..111648125,-p@chr9:111648081..111648125
-
Hg19::chr9:111648126..111648133,-p@chr9:111648126..111648133
-
Hg19::chr9:116267536..116267547,+p40@RGS3
Hg19::chr9:116916326..116916337,+p@chr9:116916326..116916337
+
Hg19::chr9:116916370..116916385,+p@chr9:116916370..116916385
+
Hg19::chr9:116916423..116916436,+p@chr9:116916423..116916436
+
Hg19::chr9:130712867..130712874,-p22@FAM102A
Hg19::chr9:139693886..139693910,+p5@KIAA1984
Hg19::chr9:14868857..14868868,-p15@FREM1
Hg19::chr9:14868978..14869003,-p7@FREM1
Hg19::chr9:14869009..14869025,-p8@FREM1
Hg19::chr9:33816391..33816411,+p@chr9:33816391..33816411
+
Hg19::chr9:706306..706335,+p@chr9:706306..706335
+
Hg19::chr9:95964201..95964224,+p@chr9:95964201..95964224
+
Hg19::chrX:131624056..131624069,-p2@MBNL3
Hg19::chrX:132727356..132727358,-p@chrX:132727356..132727358
-
Hg19::chrX:133085358..133085360,-p@chrX:133085358..133085360
-
Hg19::chrX:133119895..133119957,-p2@GPC3
Hg19::chrX:133119959..133119970,-p8@GPC3
Hg19::chrX:133119988..133119999,-p6@GPC3
Hg19::chrX:150707006..150707017,-p@chrX:150707006..150707017
-
Hg19::chrX:150707031..150707048,-p@chrX:150707031..150707048
-
Hg19::chrX:152907353..152907371,+p@chrX:152907353..152907371
+
Hg19::chrX:152907850..152907862,+p4@DUSP9
Hg19::chrX:152907913..152907937,+p3@DUSP9
Hg19::chrX:152912616..152912667,+p1@DUSP9
Hg19::chrX:152912677..152912686,+p5@DUSP9
Hg19::chrX:24208832..24208866,+p@chrX:24208832..24208866
+
Hg19::chrX:24690771..24690782,-p12@PCYT1B
Hg19::chrX:50174557..50174568,-p@chrX:50174557..50174568
-
Hg19::chrX:50174600..50174614,-p@chrX:50174600..50174614
-
Hg19::chrX:50174615..50174630,-p@chrX:50174615..50174630
-
Hg19::chrX:50174632..50174645,-p@chrX:50174632..50174645
-
Hg19::chrX:50174653..50174669,-p@chrX:50174653..50174669
-
Hg19::chrX:50174672..50174678,-p@chrX:50174672..50174678
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

p.valueFDRnGenesnPathwayName
8.17881719741253e-050.0258859564298107332Glycine, serine and threonine metabolism (KEGG):00260
8.00199645816997e-050.02588595642981075167Protein processing in endoplasmic reticulum (KEGG):04141



Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0048523negative regulation of cellular process6.81827261879106e-05
GO:0048519negative regulation of biological process6.81827261879106e-05
GO:0005737cytoplasm0.000185855571169113
GO:0032502developmental process0.000185855571169113
GO:0009308amine metabolic process0.00294254112687248
GO:0044424intracellular part0.00294254112687248
GO:0050794regulation of cellular process0.00334723432556309
GO:0006807nitrogen compound metabolic process0.00334723432556309
GO:0005622intracellular0.00477375089228617
GO:0043066negative regulation of apoptosis0.00477375089228617
GO:0043069negative regulation of programmed cell death0.00477375089228617
GO:0005507copper ion binding0.00477375089228617
GO:0065007biological regulation0.00483481303722764
GO:0030203glycosaminoglycan metabolic process0.00647906985230723
GO:0006022aminoglycan metabolic process0.00647906985230723
GO:0005515protein binding0.00648820666693384
GO:0050789regulation of biological process0.00745643247276909
GO:0016740transferase activity0.00928332280295425
GO:0043231intracellular membrane-bound organelle0.0104405941754571
GO:0043227membrane-bound organelle0.0104405941754571
GO:0006916anti-apoptosis0.0115121948588216
GO:0048869cellular developmental process0.0140875576165585
GO:0030154cell differentiation0.0140875576165585
GO:0048468cell development0.0141484093596958
GO:0008207C21-steroid hormone metabolic process0.0159869972467686
GO:0000074regulation of progression through cell cycle0.0159869972467686
GO:0051726regulation of cell cycle0.0162629714021646
GO:0000188inactivation of MAPK activity0.0162629714021646
GO:0009653anatomical structure morphogenesis0.0181033809190882
GO:0007040lysosome organization and biogenesis0.0188059199735649
GO:0007033vacuole organization and biogenesis0.0217307969928773
GO:0045786negative regulation of progression through cell cycle0.0217307969928773
GO:0043229intracellular organelle0.0224235476719124
GO:0043226organelle0.0224235476719124
GO:0006915apoptosis0.0224235476719124
GO:0043407negative regulation of MAP kinase activity0.0224235476719124
GO:0012501programmed cell death0.0224235476719124
GO:0022402cell cycle process0.0224235476719124
GO:0016043cellular component organization and biogenesis0.0232054936195745
GO:0008219cell death0.0276202546581823
GO:0016265death0.0276202546581823
GO:0000287magnesium ion binding0.0285112543427892
GO:0001525angiogenesis0.0306533952330491
GO:0016263glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity0.0306533952330491
GO:0004760serine-pyruvate transaminase activity0.0306533952330491
GO:0046724oxalic acid secretion0.0306533952330491
GO:0060155platelet dense granule organization and biogenesis0.0306533952330491
GO:0042866pyruvate biosynthetic process0.0306533952330491
GO:0016656monodehydroascorbate reductase (NADH) activity0.0306533952330491
GO:0019265glycine biosynthetic process, by transamination of glyoxylate0.0306533952330491
GO:0051657maintenance of organelle localization0.0306533952330491
GO:0008812choline dehydrogenase activity0.0306533952330491
GO:0043691reverse cholesterol transport0.0306533952330491
GO:0051659maintenance of mitochondrion localization0.0306533952330491
GO:0021904dorsoventral neural tube patterning0.0306533952330491
GO:0015677copper ion import0.0306533952330491
GO:0001822kidney development0.0322183147854345
GO:0044464cell part0.036485895133149
GO:0001655urogenital system development0.036485895133149
GO:0048514blood vessel morphogenesis0.036485895133149
GO:0016772transferase activity, transferring phosphorus-containing groups0.036485895133149
GO:0051235maintenance of localization0.036485895133149
GO:0000165MAPKKK cascade0.036485895133149
GO:0048646anatomical structure formation0.036485895133149
GO:0048856anatomical structure development0.036485895133149
GO:0016301kinase activity0.036485895133149
GO:0001568blood vessel development0.036485895133149
GO:0001944vasculature development0.036485895133149
GO:0016773phosphotransferase activity, alcohol group as acceptor0.036485895133149
GO:0032331negative regulation of chondrocyte differentiation0.036485895133149
GO:0006670sphingosine metabolic process0.036485895133149
GO:0033700phospholipid efflux0.036485895133149
GO:0021532neural tube patterning0.036485895133149
GO:0004105choline-phosphate cytidylyltransferase activity0.036485895133149
GO:0033363secretory granule organization and biogenesis0.036485895133149
GO:0055091phospholipid homeostasis0.036485895133149
GO:0008481sphinganine kinase activity0.036485895133149
GO:0030810positive regulation of nucleotide biosynthetic process0.036485895133149
GO:0043072negative regulation of non-apoptotic programmed cell death0.036485895133149
GO:0032387negative regulation of intracellular transport0.036485895133149
GO:0030816positive regulation of cAMP metabolic process0.036485895133149
GO:0045981positive regulation of nucleotide metabolic process0.036485895133149
GO:0004996thyroid-stimulating hormone receptor activity0.036485895133149
GO:0030801positive regulation of cyclic nucleotide metabolic process0.036485895133149
GO:0030349syntaxin-13 binding0.036485895133149
GO:0003943N-acetylgalactosamine-4-sulfatase activity0.036485895133149
GO:0030804positive regulation of cyclic nucleotide biosynthetic process0.036485895133149
GO:0030819positive regulation of cAMP biosynthetic process0.036485895133149
GO:0021978telencephalon regionalization0.036485895133149
GO:0004371glycerone kinase activity0.036485895133149
GO:0042981regulation of apoptosis0.036485895133149
GO:0043067regulation of programmed cell death0.036485895133149
GO:0008289lipid binding0.036485895133149
GO:0007049cell cycle0.036485895133149
GO:0017076purine nucleotide binding0.036485895133149
GO:0009887organ morphogenesis0.036485895133149
GO:0031325positive regulation of cellular metabolic process0.036485895133149
GO:0046983protein dimerization activity0.036485895133149
GO:0044237cellular metabolic process0.036485895133149
GO:0030554adenyl nucleotide binding0.036485895133149
GO:0033043regulation of organelle organization and biogenesis0.036485895133149
GO:0051493regulation of cytoskeleton organization and biogenesis0.036485895133149
GO:0006469negative regulation of protein kinase activity0.036485895133149
GO:0033673negative regulation of kinase activity0.036485895133149
GO:0051348negative regulation of transferase activity0.036485895133149
GO:0005768endosome0.036485895133149
GO:0051496positive regulation of stress fiber formation0.036485895133149
GO:0016151nickel ion binding0.036485895133149
GO:0052185modification of structure of other organism during symbiotic interaction0.036485895133149
GO:0051883killing of cells in other organism during symbiotic interaction0.036485895133149
GO:0004687myosin light chain kinase activity0.036485895133149
GO:0017050D-erythro-sphingosine kinase activity0.036485895133149
GO:0051495positive regulation of cytoskeleton organization and biogenesis0.036485895133149
GO:0052331hemolysis by organism of red blood cells in other organism during symbiotic interaction0.036485895133149
GO:0019836hemolysis by symbiont of host red blood cells0.036485895133149
GO:0045662negative regulation of myoblast differentiation0.036485895133149
GO:0051801cytolysis of cells in other organism during symbiotic interaction0.036485895133149
GO:0004873asialoglycoprotein receptor activity0.036485895133149
GO:0001907killing by symbiont of host cells0.036485895133149
GO:0031640killing of cells of another organism0.036485895133149
GO:0001897cytolysis by symbiont of host cells0.036485895133149
GO:0016244non-apoptotic programmed cell death0.036485895133149
GO:0046487glyoxylate metabolic process0.036485895133149
GO:0051818disruption of cells of other organism during symbiotic interaction0.036485895133149
GO:0008453alanine-glyoxylate transaminase activity0.036485895133149
GO:0044004disruption by symbiont of host cells0.036485895133149
GO:0051817modification of morphology or physiology of other organism during symbiotic interaction0.036485895133149
GO:0051715cytolysis of cells of another organism0.036485895133149
GO:0052332modification by organism of cell membrane in other organism during symbiotic interaction0.036485895133149
GO:0032233positive regulation of actin filament bundle formation0.036485895133149
GO:0043070regulation of non-apoptotic programmed cell death0.036485895133149
GO:0052111modification by symbiont of host structure0.036485895133149
GO:0047756chondroitin 4-sulfotransferase activity0.036485895133149
GO:0045335phagocytic vesicle0.036485895133149
GO:0052025modification by symbiont of host cell membrane0.036485895133149
GO:0052043modification by symbiont of host cellular component0.036485895133149
GO:0044003modification by symbiont of host morphology or physiology0.036485895133149
GO:0052188modification of cellular component in other organism during symbiotic interaction0.036485895133149
GO:0004700atypical protein kinase C activity0.036485895133149
GO:0030501positive regulation of bone mineralization0.036485895133149
GO:0009893positive regulation of metabolic process0.036485895133149
GO:0044421extracellular region part0.0388616519307626
GO:0006629lipid metabolic process0.0433429772800992
GO:0005578proteinaceous extracellular matrix0.0433429772800992
GO:0032366intracellular sterol transport0.0433429772800992
GO:0004682protein kinase CK2 activity0.0433429772800992
GO:0006545glycine biosynthetic process0.0433429772800992
GO:0015643toxin binding0.0433429772800992
GO:0004694eukaryotic translation initiation factor 2alpha kinase activity0.0433429772800992
GO:0046717acid secretion0.0433429772800992
GO:0042448progesterone metabolic process0.0433429772800992
GO:0001542ovulation from ovarian follicle0.0433429772800992
GO:0032365intracellular lipid transport0.0433429772800992
GO:0021871forebrain regionalization0.0433429772800992
GO:0032367intracellular cholesterol transport0.0433429772800992
GO:0032330regulation of chondrocyte differentiation0.0433429772800992
GO:0045987positive regulation of smooth muscle contraction0.0433429772800992
GO:0007500mesodermal cell fate determination0.0433429772800992
GO:0048522positive regulation of cellular process0.0433964226191836
GO:0048037cofactor binding0.0436614399545067
GO:0007275multicellular organismal development0.0443120627656638
GO:0008202steroid metabolic process0.0448004525197154
GO:0016567protein ubiquitination0.0450379268749544
GO:0005604basement membrane0.0459539309475378
GO:0004674protein serine/threonine kinase activity0.0468111641542894
GO:0006066alcohol metabolic process0.0468111641542894
GO:0017016Ras GTPase binding0.0468111641542894
GO:0032446protein modification by small protein conjugation0.0468111641542894
GO:0051646mitochondrion localization0.0468111641542894
GO:0045669positive regulation of osteoblast differentiation0.0468111641542894
GO:0001537N-acetylgalactosamine 4-O-sulfotransferase activity0.0468111641542894
GO:0046521sphingoid catabolic process0.0468111641542894
GO:0030728ovulation0.0468111641542894
GO:0008045motor axon guidance0.0468111641542894
GO:0006656phosphatidylcholine biosynthetic process0.0468111641542894
GO:0048038quinone binding0.0468111641542894
GO:0042787protein ubiquitination during ubiquitin-dependent protein catabolic process0.0468111641542894
GO:0017049GTP-Rho binding0.0468111641542894
GO:0030817regulation of cAMP biosynthetic process0.0468111641542894
GO:0045933positive regulation of muscle contraction0.0468111641542894
GO:0045931positive regulation of progression through mitotic cell cycle0.0468111641542894
GO:0017166vinculin binding0.0468111641542894
GO:0045859regulation of protein kinase activity0.0468111641542894
GO:0032555purine ribonucleotide binding0.0468815153537965
GO:0032553ribonucleotide binding0.0468815153537965
GO:0043549regulation of kinase activity0.0487375625284291
GO:0000151ubiquitin ligase complex0.0494411935086935
GO:0051338regulation of transferase activity0.0494411935086935
GO:0031267small GTPase binding0.0494411935086935
GO:0016323basolateral plasma membrane0.0494411935086935
GO:0005524ATP binding0.0494411935086935
GO:0046688response to copper ion0.0494411935086935
GO:0033344cholesterol efflux0.0494411935086935
GO:0015991ATP hydrolysis coupled proton transport0.0494411935086935
GO:0005956protein kinase CK2 complex0.0494411935086935
GO:0045661regulation of myoblast differentiation0.0494411935086935
GO:0005007fibroblast growth factor receptor activity0.0494411935086935
GO:0030802regulation of cyclic nucleotide biosynthetic process0.0494411935086935
GO:0043682copper-transporting ATPase activity0.0494411935086935
GO:0030808regulation of nucleotide biosynthetic process0.0494411935086935
GO:0051492regulation of stress fiber formation0.0494411935086935
GO:0004008copper-exporting ATPase activity0.0494411935086935
GO:0045778positive regulation of ossification0.0494411935086935
GO:0032231regulation of actin filament bundle formation0.0494411935086935
GO:0030814regulation of cAMP metabolic process0.0494411935086935
GO:0000902cell morphogenesis0.0494411935086935
GO:0032989cellular structure morphogenesis0.0494411935086935
GO:0043086negative regulation of catalytic activity0.0494411935086935



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen
metabolising cell8.61e-3812
endopolyploid cell8.61e-3812
parenchymal cell8.61e-3812
polyploid cell8.61e-3812
hepatocyte8.61e-3812
endodermal cell1.72e-1458
intestinal epithelial cell1.29e-134
Uber Anatomy
Ontology termp-valuen
liver2.73e-2419
digestive gland2.73e-2419
liver bud2.73e-2419
hepatic diverticulum3.99e-2122
liver primordium3.99e-2122
digestive tract diverticulum2.97e-2023
epithelial sac1.02e-1825
epithelium of foregut-midgut junction1.02e-1825
anatomical boundary1.02e-1825
hepatobiliary system1.02e-1825
foregut-midgut junction1.02e-1825
septum transversum1.02e-1825
sac4.90e-1826
gut epithelium1.70e-1554
exocrine gland2.73e-1531
exocrine system2.73e-1531
endocrine gland1.18e-1335
intestinal mucosa1.29e-134
wall of intestine1.29e-134
gastrointestinal system mucosa1.29e-134
gastrointestinal system epithelium1.29e-134
intestinal epithelium1.29e-134
endocrine system7.94e-1145
endo-epithelium1.66e-1082
abdomen element3.61e-0954
abdominal segment element3.61e-0954
gland1.83e-0859
abdominal segment of trunk2.45e-0860
abdomen2.45e-0860
subdivision of digestive tract1.75e-07118
epithelium of mucosa1.80e-078
simple columnar epithelium8.85e-079
Disease
Ontology termp-valuen
disease of anatomical entity2.38e-1239


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.15.79456e-09
MA0004.10.0773024
MA0006.10.00364569
MA0007.10.307905
MA0009.10.219969
MA0014.12.63594e-10
MA0017.131.8051
MA0019.10.0820964
MA0024.10.0916718
MA0025.11.04535
MA0027.10.945851
MA0028.10.000439089
MA0029.11.4721
MA0030.10.0989656
MA0031.10.276963
MA0038.10.172086
MA0040.10.504739
MA0041.11.90107
MA0042.11.4743
MA0043.10.114583
MA0046.112.7236
MA0048.10.0808186
MA0050.10.134812
MA0051.11.97022
MA0052.10.0571998
MA0055.10.00400339
MA0056.10
MA0057.10.00605178
MA0058.10.0515274
MA0059.10.403534
MA0060.11.59427
MA0061.10.464645
MA0063.10
MA0066.10.342925
MA0067.10.154982
MA0068.10.156424
MA0069.10.335363
MA0070.10.692398
MA0071.10.955425
MA0072.10.0882581
MA0073.10.000339525
MA0074.10.431075
MA0076.12.22509e-05
MA0077.10.647178
MA0078.11.46655
MA0081.10.0500798
MA0083.10.583448
MA0084.10.681902
MA0087.10.90957
MA0088.10.00222108
MA0089.10
MA0090.13.73388
MA0091.10.316121
MA0092.10.315569
MA0093.10.0311995
MA0095.10
MA0098.10
MA0100.10.519975
MA0101.10.289317
MA0103.10.0206402
MA0105.10.000186152
MA0106.11.98315
MA0107.10.525865
MA0108.20.561138
MA0109.10
MA0111.10.739895
MA0113.10.0976176
MA0114.128.5167
MA0115.13.62436
MA0116.10.480351
MA0117.10.0214542
MA0119.10.801893
MA0122.10.330892
MA0124.10.202851
MA0125.10.0083642
MA0130.10
MA0131.10.40361
MA0132.10
MA0133.10
MA0135.10.918826
MA0136.10.0783561
MA0139.10.326951
MA0140.10.933604
MA0141.17.67338
MA0142.10.45415
MA0143.11.15397
MA0144.12.45081
MA0145.10.333015
MA0146.10.302069
MA0147.10.0245253
MA0148.14.34773
MA0149.10.443504
MA0062.20.0010129
MA0035.22.25182
MA0039.22.48573e-05
MA0138.20.05266
MA0002.20.963896
MA0137.20.473174
MA0104.20.00329929
MA0047.25.28977
MA0112.21.54185
MA0065.25.6609
MA0150.10.061649
MA0151.10
MA0152.10.663903
MA0153.16.41566
MA0154.10.966122
MA0155.10.28604
MA0156.10.261369
MA0157.10.363183
MA0158.10
MA0159.11.16594
MA0160.15.45722
MA0161.10
MA0162.15.12936e-10
MA0163.10.0734363
MA0164.11.75384
MA0080.20.271601
MA0018.20.00374053
MA0099.20.157954
MA0079.23.6765e-13
MA0102.20.376414
MA0258.12.91321
MA0259.10.196479
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
BHLHE40#8553446.037797541489322.74165853888483e-217.36082457950111e-19
CEBPB#1051992.413283226167152.35453162381174e-174.89850454699749e-15
ELF1#19971001.302170629604750.001943037835160520.011413325560536
EP300#20332264.681684495799522.71867204467815e-1095.35727150328568e-106
ESRRA#21011014.79633988183872.37215174195383e-092.01746869525991e-07
FOSL2#2355975.022108436215555.09290682880948e-412.9714977446594e-38
FOXA1#31691796.065975948440361.25871421917174e-972.0540445990012e-94
FOXA2#317015911.97628054028681.37226715457362e-1283.18484909681144e-125
HDAC2#30661797.343718722801531.75896583135508e-1113.60205161688025e-108
HEY1#234622773.422357060979451.46709162432103e-1153.06443164304929e-112
HNF4A#317219713.935966977077.97234088125446e-1792.60194784155417e-175
HNF4G#317420117.67412210341228.58644119977634e-2043.89895361940627e-200
JUND#3727641.368986214922770.00535393762168590.0245957548724929
MAFF#23764264.477673604705123.47578549461043e-103.48375778571611e-08
MAFK#7975393.23219753019991.81442778230609e-101.88930232458889e-08
POLR2A#54302521.654918044319981.64835325745213e-296.49631569264312e-27
PPARGC1A#1089155.35246385877120.002658942261731340.0146727925009489
RXRA#62561559.515491304482135.13663912805526e-1101.03166433441339e-106
SIN3A#25942941.554847597310774.11211014306236e-060.000130576063007385
SP1#66672163.764068433267388.98779606515958e-841.15885979413482e-80
SREBF1#6720253.593719376184125.58328289654898e-083.5000749245659e-06
SREBF2#672156.681089639317240.001014355484724930.00719640462395131
SRF#6722461.940887461956331.35079318783528e-050.000327473281672074
TAF1#68721231.25747612583080.001698800888485130.0106138469725113
TBP#69082022.289809415270551.40749483729893e-398.03264225752254e-37
TCF12#6938501.626064969753280.0004505353684410190.00419035206559903
TCF7L2#69341825.994410197220177.72946104802088e-991.281360606975e-95
USF1#7391691.342334709869570.00597075146922380.0267757015197847



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C55&oldid=3067173"